Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay.

Exposure to surgeon early adopters through peer networks and co-location was predictive of ODX uptake by medical oncologists and testing of patients. Interventions focused on the role of surgeons in molecular testing may improve the implementation of best practices in breast cancer care.